Showing results (1991-2000 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|August 26, 2018
Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective AnalysisMark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.CNS Drugs|May 8, 2019
Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional StudyBruno Agustini, Mohammadreza Mohebbi, Robyn L Woods, et al.CNS Drugs|June 27, 2019
Outcome Assessment in Trials of Pharmacological Treatments for Alcohol Use Disorders: Fair and Strict TestingSusanne Rösner, Michael SoykaCNS Drugs|June 24, 2017
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseEva Schaeffer, Daniela BergCNS Drugs|March 31, 2023
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its UseYoung-A HeoCNS Drugs|March 29, 2021
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic StudyFederico Bertolini, Giovanni Ostuzzi, Michela Pievani, et al.CNS Drugs|March 13, 2015
Infection risk in patients on multiple sclerosis therapeuticsEric M Williamson, Joseph R BergerCNS Drugs|August 12, 2020
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future VaccinationCrystal Zheng, Indrani Kar, Claire Kaori Chen, et al.CNS Drugs|August 14, 2020
Tenecteplase for Acute Ischemic Stroke: Current Evidence and Practical ConsiderationsAlejandro A Rabinstein, Esteban Golombievski, Jose BillerCNS Drugs|September 7, 2012
Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implicationsMegan Galbally, Salvatore Gentile, Andrew J LewisPageof 211